NCT01512628|Completed
Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement Arthroplasty
Hemostatic Changes After Colloid Fluid Administration During Total Hip Replacement Arthroplasty
Loading search results
Hemostatic Changes After Colloid Fluid Administration During Total Hip Replacement Arthroplasty
Sponsor study identifier
interventional
75
1 country
1
Study Start
January 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2013
Actual (reported)Study Completion
December 2013
Actual (reported)The investigators administered different kinds of colloids before transfusion of red blood cell to patient undergoing total hip replacement arthroplasty. The investigators will compare the differences of changes in rotational thromboelastometry (ROTEM) data among them.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2013
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2012
Date type not reportedThis date has not been verified as actual or estimated.
January 9, 2012
Actual (reported)January 19, 2012
Actual (reported)December 2013
Actual (reported)December 2013
Actual (reported)INTEM parameters change from preoperative values at post-operation
clotting time (sec), clot firmness time (sec), alpah angle, maximum clot firmness (mm)
30 minutes before operation and 30 minutes after operation
EXTEM parameters change from preoperative values at post-operation
clotting time (sec), clot firmness time (sec), alpah angle, maximum clot firmness (mm)
30 minutes before and 30 minutes after operation.
FIBTEM parameters change from preoperative values at post-operation
maximum clot firmness (mm)
30 min before and 30 min after operation
Infused total fluid volume
Participants will be followed for the duration of THRA operation in operating room, an expected average tiem of 3 hours
Hemoglobin
30 minutes before operation and 30 minutes after operation
postoperative blood loss
postoperative 1 day and 2 day
Hematocrit
30 minutes before operation and 30 minutes after operation
Platelet
30 minutes before operation and 30 minutes after operation
Pentaspan is administered as a colloid.
Voluven is administered as a colloid.
Volulyte is administered as a colloid.
Different colloids are administered during operation for replacement of blood loss before the transfusion of blood.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Seoul National University Bundang Hospital
Seongnam, Gyounggi, 463-707, South Korea
75 participants (actual enrollment reported by the registry).
First Submitted
January 9, 2012
First Posted
January 19, 2012
Study Start
January 2012
Date type not reportedThis date has not been verified as actual or estimated.
Safety and Effectiveness of the HIT Reverse HRS
Contact the study team to confirm eligibility.
Primary Completion
December 2013
Actual (reported)Study Completion
December 2013
Actual (reported)Last Updated
January 28, 2014
Record last verified: 2014-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: